MedTrace Logo

The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon In Prımary Pregnant Women

NCT07752693 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-08-11

No results posted yet for this study

Summary

The main objective of this study is to examine the effect of the rebozo technique, applied with partner support, on labor pain and birth satisfaction in primiparous pregnant women. This research is planned as a randomized controlled experimental study. A total of 64 pregnant women, 32 in the control group and 32 in the experimental group, who meet the sample selection criteria and agree to participate in the study, will constitute the sample of the study. Participants included in the study will be administered the Informed Consent Form, the "Demographic Information Form" created by the researcher, the "Fathers' Participation in Birth Scale", VAS scoring, "Birth Care Guide", "Observation Form Regarding Labor" and the "Birth Satisfaction Scale". Data will be analyzed using appropriate statistical methods. It is expected that the results obtained will contribute to the use of non-pharmacological methods in the birthing process and the support of partner participation.

Conditions

  • Labor Pains

Interventions

OTHER

Rebozo Technique

Rebozo technique is a traditional Mexican practice that involves relaxation, rhythmic rocking, pelvic mobilization, and position changes during pregnancy and childbirth. Theses and research examining the effects of this technique on labor indicate that the rebozo method can contribute to shortening labor time and allow the mother to be more active during delivery. In our study, unlike other rebozo techniques, the aim is to provide "partner support." The rebozo technique will be applied with partner support during the three active phases of cervical effacement and dilation (5cm, 6-8cm, and 9-10cm), and the results will be recorded.

Sponsors & Collaborators

  • Istanbul Saglik Bilimleri University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07752693 on ClinicalTrials.gov